Abstract
Background To date, there are no comprehensive data on pediatric COVID-19 from Latin America. This study aims to assess COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) in Latin American children, in order to appropriately plan and allocate resources to face the pandemic on a local and International lever
Methods Ambispective multicentre cohort study from five Latin American countries. Children aged 18 years or younger with microbiologically confirmed SARS-CoV-2 infection were included.
Findings 409 children were included, with a median age of 53.0 years (IQR 0.6–9.0). Of these, 95 191 (23.2%) were diagnosed with MIS-C. 191 (46.7%) children were admitted to hospital and 52 (12.7%) required admission to a Pediatric Intensive Care Unite (PICU). 92 (22.5%) patients required oxygen support: 8 (2%) were started on continuous positive airway pressure (CPAP) and 29 (7%) on mechanical ventilation. 35 (8.5%) patients required inotropic support. The following factors were associated with PICU admission: pre-existing medical condition (P < 0.0001), immunodeficiency (P = 0.01), lower respiratory tract infection (P< 0.0001), gastrointestinal symptoms (P = 0.006), radiological changes suggestive of pneumonia and acute respiratory distress syndrome (P< 0.0001), low socioeconomic conditions (P 0.009).
Conclusions This study shows a generally more severe form of COVID-19 and a high number of MIS-C in Latin American children, compared with studies from China, Europe and North America, and support current evidence of a more severe disease in Latin/Hyspanic children or in people of lower socioeconomic level. The findings highlight an urgent need of more data of COVID-19 in South America.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
nothing
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was reviewed and approved by the CoviDOMINGO core group and approved by the Ethic Committee of the coordinating center and by each participating center (Mexico: COMINVETICA-30072020-CEI0100120160207; Colombia: PE-CEI-FT-06; Peru: N 42-IETSI-ESSALUD-2020; Costa Rica: CEC-HNN-243-2020). The study was conducted in accordance with the Declaration of Helsinki and its amendments. No personal nor identifiable data were collected during the conduct of this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding Source No external funding for this manuscript
Financial Disclosure The authors declare they have no financial relationships relevant to this article to disclose.
Conflict of Interest The other authors have indicated they have no potential conflicts of interest to disclose.
Data sharing statement data available upon request to the corresponding author (DB)
Table of Contents Summary This study shows a high number of severe form of COVID-19 and MIS-C in Latin American Children
What’s Known on This Subject Studies from China, Europe and the United States showed that COVID-19 in children is relatively milder compared with adult. However, data are lacking from Latin America despite it has been severely affected by the pandemic
What This Study Adds This study adds new data about pediatric COVID-19 in Latin America, describing a generally more severe form of COVID-19 and a high number of MIS-C compared with previous studies
Contributors statement OYAM and DB conceived of the study. OYAM, DB, MIE designed the study. OYAM, DB and MS cleaned and analyzed the data, made the figures, wrote the first draft of the manuscript. All authors actively contributed data to the study, reviewed the manuscript, and approved the final manuscript for submission.
Data Availability
available upon request
